Ocular deposits of immune complexes are believed to contribute to the anterior segment inflammations observed in association with the human arthritides. Arthritis-related ocular inflammations may be reproduced in animals by infection with certain species of mycoplasma. To evaluate the role of immune complexes in the production of ocular lesions, we studied their involvement in the rodent model of experimental arthritisassociated ocular Vol. 60, No. 2 
Mycoplasma-induced ocular inflammation and arthritis continue to erupt in seasonal epidemics within herds of cattle, goats, and sheep. Eye and joint lesions are suspected to result from an inflammatory response to localized viable mycoplasmas and deposits of immune complexes. The initial inflammatory response to infection declines within 2 to 3 weeks after onset, sometimes leaving ocular and joint tissues irreparably damaged. Persistent carrier states can ensue during which the disease can be transmitted to offspring through colostrum and milk. Carriers occasionally experience relatively mild exacerbations of the disease indicating some, but incomplete, protection by the activated immune response (4, 17) .
The rodent model of Mycoplasma arthritidis-induced polyarthritis permits easy access to the multiple events that result in experimental arthritis, including ocular inflammations (28, 29) . Strains of M. arthritidis vary in their pathogenicity, however; virulent strains will induce symptons of eye involvement and isolated joint swelling within 1 week (30, 32) . The combination of limited joint involvement with anterior segment inflammation is not unlike that encountered in the pauciarticular variety of juvenile rheumatoid arthritis in humans (18, 23, 25) . The immune response of rats infected with M. arthritidis includes the production of complementfixing and metabolism-inhibiting antibodies, but growthinhibiting or rheumatoid factors have not been found (37) (38) (39) . Antigenic mimicry, specific tissue interactions, and immune complex involvement have been proposed as factors contributing to the pathogenicity of M. arthritidis (31) (32) (33) .
To define the role of ocular immune complexes in this model, we examined the eyes and sera of rats Western immunoblot analysis of complexes. Antigens entrapped within circulating immune complexes produced in the first set of rats were analyzed by using a polyacrylamide gel electrophoresis (PAGE) procedure based on those originally described by Matsuo et al. (21, 22) and Vinayak et al. (35) . The antibody content of 500-,ul samples of each set of test and control rat sera was absorbed onto Pansorbin (Calbiochem). The mixture was incubated at room temperature with agitation for 1 h, and the Pansorbin was collected by centrifugation. Bound immunoglobulins and their related antigens were eluted from the Pansorbin by boiling for 10 min in PAGE sample buffer (13) . The supernatant was electrophoresed on a 1.5-mm-thick, 20-cm 12% polyacrylamide gel and blot transferred to nitrocellulose (34) . The transfer was blocked in PBS containing 0.5% Tween and 0.05% nonfat milk before being probed with rabbit anti-M. arthritidis serum at a dilution of 1:1,000. Mycoplasma antigens, present in serum samples obtained over the initial 30-day period prior to challenge, were subsequently resolved by using goat anti-rabbit IgG-horseradish peroxidase conjugate reacting on the substrate 3,3'-diaminobenzidine. This technique was confined to the first set of rats that experienced a single infective dose, since its application to those receiving a secondary challenge would reflect that of previously sensitized animals.
The competence of the rabbit anti-M. arthritidis serum prepared in this laboratory to identify the antigens of M. arthritidis in Western blot reactions was compared with the activity of pooled rat sera obtained from day 30 of the study.
Both were evaluated at a dilution of 1:1,000 in side-by-side reactions on the same blot transfer of strain 14152 of M. arthritidis.
RESULTS
Conjunctivitis appeared in all test animals in the first set within in 24 h postinfection but was resolved completely by day 5. Intravitreal leukocyte infiltration, indicting intraocular inflammation, was found histologically in only 5 of the first set of 18 test rats (3 on day 15 and 2 on day 20) and in none of the second set of challenged animals. Swollen joints appeared in all test rats on day 5 and continued throughout the first 30 days of the study, following the same pattern which we and others have previously described (28, 29) . Viable mycoplasmas were present in blood samples obtained from the first group on day 5, but not thereafter. Secondary challenge on day 35 again produced a similar pattern of septicemia, with viable isolates present in blood only on day 40, 5 days postchallenge, and not thereafter (Fig. 1) . No evidence of overt joint or eye involvement appeared in the secondary challenge group of rats. Uninfected control rats, injected with complete serum-supplemented culture medium, showed no response in any of the parameters examined throughout the study.
ELISA antibody assay. Overall antibody response to infection showed an elevation in antibody reactions to M. arthritidis antigens which increased rapidly to peak and persist throughout the first phase of the study period. Serum from uninfected control rats assayed under the same conditions gave background readings against which the antibody reac- tions of the infected rats were compared. There was no appreciable increase in the overall antibody response following challenge (Fig. 1) .
ELISA antigen capture system. Since living mycoplasmas were demonstrable in the blood of test animals 5 days following both initial exposure and secondary challenge, complexes captured during the transient septicemia were not considered representative of true immune complexes. Circulating antibody complexed with non-viable M. arthritidis antigens was detected on day 10 and thereafter in decreasing concentrations in all test serum samples until day 30 following initial infection. Secondary challenge resulted in the reappearance of high concentrations of circulating immune complexes, which again declined progressively to the end of the study (Fig. 1) .
Immunohistochemistry. Examination of sectioned eyes from infected rats, obtained on days 5 through 30, showed the early appearance of intense immunofluorescence indicating the present of mycoplasma antigens, aggregated C3, and rat immunoglobulins entrapped within the iris-ciliary microvasculature (Fig. 2) . These reactions were most intense during the first 15 days following infection, but declined rapidly to day 30, when no immunofluorescence was detectable. The second set of rats, reinfected on day 35, exhibited a similar pattern of localized complexes. Reactions were most intense on day 40 and gradually declined to zero at the end of the study on day 65. After challenge, secondary deposits of mycoplasma antigens, complement, and immunoglobulins occurred and declined in the complete absence of arthritic and ocular signs. Eyes from uninfected control rats showed no abnormalities.
Western immunoblot analysis of complexes. M. arthritidis antigens present in captured immunoglobulin complexes were detected in decreasing quantities on days 10, 15, and 20. The principal antigen resolved by the rabbit anti-M. arthritidis serum exhibited a relative molecular mass of approximately 65 kDa and was present in serum samples from days 10 to 20, after which no further reactions were found by this method. Serum from uninfected control rats gave no reaction in this assay (Fig. 3a) . Western blot assays of the rabbit anti-M. arthritidis sera and pooled rat sera obtained from test rats on day 30 showed similar immunoreactivity when compared on a blot transfer of M. arthritidis (Fig. 3b) .
DISCUSSION
Mycoplasmas produce an assortment of ocular inflammations in a variety of animals, but the pathogenic process is not fully understood. The M. arthritidis model of arthritisassociated ocular inflammation shares similarities with the human arthritides. Ocular lesions associated with rheumatoid arthritis may result from soluble circulating immune complexes which eventually deposit within the blood vessels of the eye and initiate localized inflammatory reaction (23). Char et al. (5) showed a correlation between the relative concentrations of circulating immune complexes and the severity of ocular inflammation in patients with chronic uveitis and iridocyclitis. Howes and McKay (15) demonstrated increased vascular permeability in rabbits in which they had produced immune complexes and associated the occurrence of localized lesions with intravascular deposits. However, the mere presence of intraocular immune complexes cannot be held solely responsible for the induction of uveitis since Hylkema et al. (16) healthy humans who exhibit none of the effects usually associated with immune complexes (11, 12, 20) . Some predisposing events, such as trauma or infection of specific tissues, may be required to involve immune complexes in the production of the lesions found in immune complex diseases (24) .
Kirchhoff et al. (19) described fluctuating levels of immune complexes circulating in the sera and localized in joints of M. arthritidis-infected rats which were resistant to secondary infection. As in our study, they reported that viable mycoplasmas circulating in the blood immediately after the tail vein inoculation were rapidly cleared, leaving only fragmented or dead mycoplasmas trapped with related antibodies detectable in serum samples. Although no longer present in the blood, viable mycoplasmas reportedly have been isolated from a variety of organs, with joint isolates evident up to 200 days following infection (14) .
A complete understanding of the so-called immune complex disease requires identification of the antigen within the complex. In some cases of recognized autoimmune diseases, the antigens contained in associated immune complexes have been identified and incriminated in the disease process. For example, rheumatoid factors consist of antibodies reacting with other antibodies, and lupus erythematosus is associated with anti-DNA complexes. In recent years, antigen capture systems similar to those described here have identified some of the antigens involved in diseases with known and suspected immune complex involvement. These include the detection of retinal S-antigen-antibody complexes in the blood serum of patients with uveitis (22) , specific DNA sequences in lupus erythematosus (3), hepatitis B antigens (26) , and circulating herpes virus antigens (21) . In the present study, Western blot analysis of circulating antibodybound M. arthritidis antigens demonstrated the presence of several mycoplasma antigens in blood sera assayed 10 days postinfection. A rapid decline ensued to day 20, when only a single reaction with an antigen-antibody reaction approximating 65 kDa was resolved. After day 20, no further immunological reactions could be resolved by using the Western blot antigen capture system described here. The intensity of the 65-kDa reaction suggests that this mycoplasma protein represents a major antigenic component of M. arthritidis. It should be understood that antigenic processing in the infected rats may have resulted in modifications to this component which could exhibit a different size when identified in a fresh culture extract.
While all infected rats in the first group of 18 experienced transient conjunctivitis, only 5 exhibited indications of intraocular inflammation. Although immune complexes may be involved in the production of the recorded ocular lesions, they are not the only contributing factor since secondary ocular deposits incited in the challenged group of reinfected rats failed to provoke any pathological response. Overall antibody response rose only slighly following challenge, indicative of saturation titers or the limitations of the assay procedures used in this study. This anomaly may add to the controversy surrounding the humoral immune response of rats following infection with M. arthritidis (37).
We have previously described the isolation of viable mycoplasmas from enucleated eyes and ocular exudates of M. arthritidis-infected rodents (29, 33) . It is therefore possible that intraocular complex deposits include viable mycoplasmas, capable of survival and reproduction. Localized modulation of the host's immune response could accordingly occur since metabolic by-products of M. arthritidis are known to have both stimulatory and inhibitory effects on leucocyte behavior (1, 2, 6-10).
We conclude that in the Sprague-Dawley rat model of M. arthritidis-induced arthritis-associated ocular inflammations, eye reactions occur only in newly infected animals. Conjunctivitis is the most consistent ocular feature of the disease, while introcular inflammations occur with a much lower frequency. The presence of intraocular immune complexes cannot be held solely responsible for the associated eye changes since their reproduction in previously sensitized rats fails to incite any pathological response. The ocular events which we have shown to occur in naive animals may require predisposing factors, such as tissue damage induced by the initial exposure to some yet-to-be-defined cytotoxic product of the mycoplasma. However, once the rat is sensitized to the mycoplasma product, any subsequent exposure is neutralized by the protection ensuing from the primary response to infection. The rat model therefore fails to reflect the most significant feature of arthritis-associated ocular inflammations in humans, a chronic anterior segment involvement (iridocyclitis) characterized by progressive inflammation linked to immune complex deposits.
